Site hosted by Angelfire.com: Build your free website today!
  METABOLIC THERAPY IN CANCER
The use of Amygdalin (Vitamin B-17)
 
by Harold W. Manner, Ph.D.
Metabolic Research Foundation
in collaboration with
Clinica Manner and
Cyto Pharma de Mexico, S.A.

Metabolic Therapy

In Recent years a significant reassessment of nature and causes of cancer has taken place. Cancer was formerly believed to be a localized disease, characterized by a lesion, usually in the form of a growth, which appeared at some specific part of the body. This Localized lesion was thought to be the result of activity produced by an invading virus, carcinogenic agent or some form of trauma such as a blow.

Today, there is a growing conviction among researchers and physicians that cancer is a complex disease that is the end result of a disturbed metabolism (body chemistry). It is an insidious disease that involves the entire body; the nervous system, digestive tract, pancreas, lungs, excretory organs, endocrine system, and the entire defense mechanisms. The frequent reoccurrence of a malignancy after treatment with the conventional methods of surgery, radiation and/or chemotherapy, results because the basic underlying metabolic cause of the cancer is rarely considered and consequently remains uncorrected.

In the human body there are many thousands of cells that are arrested, during development, at an embryonic stage. These cells are called mesenchymal cells, fibroblasts, neoblasts, etc. Their primary function is repair. When a bone is broken, these cells can develop into bone cells. If blood is lost, these same cells are able to transform into blood cells. They are truly pluripotential and can react to any number of morphogenetic stimuli. These same cells, when subjected to carcinogens (cancer-causing chemicals) develop into cancer cells. Each day, in every human being, large numbers of these normal embryonic cells become cancerous. They rarely, however, become the disease that we call cancer due to a remarkable system called the immune system. The function of this system is to destroy or neutralize all foreign material in the body. Once an embryonic cell becomes a cancer cell it is, from a biochemical view, foreign to the body. We, therefore, continue to remain healthy because the lymphocytes, macrophages, and other components of the immune system are able to neutralize or destroy these cells and prevent their spreading and multiplication. These cancer cells are normally destroyed by our body's defense mechanisms within a few hours.

If the immune system, however, is weakened from poor nutrition, excessive environmental pollutants or a continuing debilitating stress, the cancer cells are uninhibited and will multiply rapidly forming the symptomatic "growth" of cancer. Our immune system generally weakens with advancing age. This increases the possibility of degenerative metabolic diseases occurring. One of the primary objectives of all metabolic therapy is to revitalize the body's immune system, to restore it to a fully functional condition. Accomplishment of this goal permits the immune system to eliminate or otherwise negate the cancer cells before they can begin an invasive growth.

Metabolic Physicians and researchers believe that we can remain healthy if we supply the individual cells of the body with the proper amounts of oxygen, nutrients, enzymes, minerals, amino acids, and other essential nutrients from both our diet and nutritional supplements. Of equal importance is the ability of the body to eliminate the waste products of cellular metabolism through the proper bowel movements, efficient breathing, normal excretion, etc. Treatments must be provided which will help the body detoxify itself by eliminating harmful pollutants. This, in essence, is the heart of metabolic therapy. It is a multi-faceted program incorporating numerous related elements, each of which plays an important role in the success of the complete therapy.

Amygdalin (Vitamin B-17) is a relatively simple compound found in much of our food supply. It is most abundant in the seeds of non-citrus fruits. Most commercially prepared Amygdalin is extracted from the seeds of the apricot. Amygdalin is composed of two molecules of glucose (a sugar), one molecule of benzaldehyde (an analgesic) and one molecule of hydrocyanic acid (an anti-neoplastic compound).

In metabolic therapy, the Amygdalin is broken down into its component parts as a result of the action of beta-glucosidase. This enzyme is found in abundance in cancer cells, and is relatively deficient in normal cells. Consequently, the cyanide is released only where there is an active cancer lesion. This liberation of cyanide under controlled and safe conditions insures that an adequate dosage can be administered without the threat of toxic side effects. This absence of cyanide toxicity is further insured by the action of Rhodanese, another enzyme. This enzyme is present in large quantities in normal cells but in very small amounts in cancer cells. Detoxification of cyanide occurs, therefore, in normal mammalian tissue through the action of Rhodanese which, in the presence of sulfur-bearing compounds, converts free cyanide to thiocyanate, a perfectly non-toxic compound. The thiocyanate is excreted in the urine.

 
[ The Ultimate Cancer Conspiracy ]
[ Metabolic Therapy in Cancer ] [ Nutritional and Therapeutic Implications ]
[ Graphic on Action of B-17 in Cancer ] [ The Nature of Cancer by Dr. Ernest T. Krebs ]
[ Ralph Moss on Chemotherapy, Laetrile, Coley's Toxins, Burzynski, & Cancer Politics ]
[ The Nitrilosides (B-17) - Nature, Occurrence and Metabolic Significance ]
[ Ernest T. Krebs, Jr. Discoverer of Vitamin B-17 (Biography) ]
[ Unitarian or Trophoblastic Thesis of Cancer ]
[ The Hunza ] [ Product Information ]
[ Online Store ]
 
HOME
 
© RCS & Cancer Gone
P.O. Box 1156
Crawfordsville, IN 47933 U.S.A
Tel: 219-745-0647
Fax: 765-364-0367
Toll Free
 
CANCERGONE@BIGFOOT.COM